Patent Assignment
Reel/Frame 036518/0862
Release of Security Interest
Recorded: 2015-09-01
Pages: 19
Assignor
MACQUARIE US TRADING LLC
Executed: 2015-08-28
Assignee
KADMON CORPORATION, LLC
400 MADISON AVENUE, NEW YORK, NEW YORK, 10017
Covered Properties
(69)
Metalloproteinase Binding Proteins
PCT:
PCT/US2006/049566 ↗
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic Diagnostic and Prognostic Methods for Cancer
PCT:
PCT/US2008/087230 ↗
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
PCT:
PCT/US2008/087236 ↗
Metalloproteinase Binding Proteins
PCT:
PCT/US2009/032384 ↗
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-Mmp-14 Antibodies
PCT:
PCT/US2009/041632 ↗
Combination Treatments Comprising Protease Binding Proteins for Inflammatory Disorders
PCT:
PCT/US2009/061717 ↗
Inhibitors of Mtor Kinase as Anti-Viral Agents
PCT:
PCT/US2010/043101 ↗
Receptor-Type Kinase Modulator and Methods of Treating Polycystic Kidney Disease
PCT:
PCT/US2011/049077 ↗
Inhibitors of Mtor Kinasa as Anti- Viral Agents
PCT:
PCT/US2012/023035 ↗
Anti-Viral Combination Therapy
PCT:
PCT/US2012/032567 ↗
Methods for Treatment of Breast Cancer Nonresponsive to Trastuzumab
PCT:
PCT/US2012/071883 ↗
Farnesyl Derivatives and Pharmaceutical Compositions Containing Them
Patent:
5,705,528 →
Application:
08/338,764 →
Non-Malignant Disease Treatment with Ras Antagonists
Patent:
6,462,086 →
Application:
09/597,332 →
Herbal Composition PHY906 and Its Use in Chemotheraphy
Treatment of Post-Angioplasty Restenosis and Atherosclerosis with Ras Antagonists
Receptor-Type Kinase Modulators and Methods of Use
Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist
Application:
10/560,209 →
Publication:
US 2007/0036795
Herbal Composition PHY906 and Its Use in Chemotherapy
Inhibitors of Microsomal Triglyceride Transfer Protein and Apo-B Secretion
Antibodies That Bind Mmp-14
Methods and Compositions for Oral Delivery of Fts
Pharmacokinetically Improved Compounds
Treatment of Viral Infections by Modulation of Host Cell Metabolic Pathways
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Methods of Inhibiting Receptor Tyrosine Kinases with an Extracellular Antagonist and an Intracellular Antagonist
Application:
12/361,350 →
Publication:
US 2009/0232805
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
Application:
12/429,338 →
Publication:
US 2009/0275124
Receptor-Type Kinase Modulators and Methods of Use
Treatment of Lung Cancer
Herbal Composition PHY906 and Its Use in Chemotherapy
Alkoxyalkyl S-Prenylthiosalicylates for Treatment of Cancer
Use of PHY906 as Treatment for Inflammatory Bowel Disease and/or Irritable Bowel Syndrome
Application:
12/739,591 →
Publication:
US 2011/0111070
Metalloproteinase Binding Proteins
Use of the Combination of PHY906 and a Tyrosine Kinase Inhibitor as a Cancer Treatment Regimen
Combination Treatments Comprising Protease Binding Proteins for Inflammatory Disorders
Application:
13/124,046 →
Publication:
US 2011/0262396
Rho Kinase Inhibitors
Application:
13/255,879 →
Publication:
US 2012/0202793
Methods and Compositions for Oral Delivery of Fts
Application:
13/326,598 →
Publication:
US 2012/0082722
Method for Treating Breast Cancer Using Antibody Binding to Mmp-14
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Inhibitors of Mtor Kinase as Anti-Viral Agents
Application:
13/386,547 →
Publication:
US 2012/0190676
Inhibition of Glycerol-3-Phosphate Acyltransferase (GPAT) and Associated Enzymes for Treatment of Viral Infections
Treatment of Viral Infections by Modulation of Host Cell Metabolic Pathways
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Application:
13/454,534 →
Publication:
US 2013/0244890
Treatment of Multiple Sclerosis
Application:
13/521,637 →
Publication:
US 2013/0035390
Treatment of Lung Cancer
Application:
13/559,737 →
Publication:
US 2012/0294957
Inhibitors of Long and Very Long Chain Fatty Acid Metabolism as Broad Spectrum Anti-Virals
Herbal Composition PHY906 and Its Use in Chemotherapy
Application:
13/648,597 →
Publication:
US 2013/0101688
Pharmacokinetically Improved Compounds
Pharmacokinetically Improved Compounds
Dengue Virus and Yellow Fever Virus Therapies
Application:
14/241,010 →
Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
Application:
60/477,796 →
Metalloproteinase binding proteins
Application:
60/755,376 →
Metalloproteinase Binding Proteins
Application:
60/805,567 →
Metalloproteinase Binding Proteins
Application:
60/870,566 →
Metalloproteinase Binding Proteins
Application:
61/024,703 →
Evaluating Mmp Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Application:
61/025,017 →
Compositions and Methods for Treating Osteolytic Disorders Comprising Mmp-14 Binding Proteins
Application:
61/025,032 →
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-Mmp-14 Antibodies
Application:
61/047,787 →
Combination Treatments Comprising Protease Binding Proteins for Inflammatory Disorders
Application:
61/107,384 →
Inhibitors of Long and Very Long Chain Fatty Acid Metabolism as Broad Spectrum Anti-Virals
Application:
61/305,862 →
Receptor-Type Kinase Modulator and Methods of Treating Polycystic Kidney Disease
Application:
61/377,211 →
Evaluating Protein Expression in Patient Stratification and Other Therapeutic, Diagnostic and Prognostic Methods for Cancer
Application:
61/467,305 →
Anti-Viral Combination Therapy
Application:
61/472,608 →
Combination Therapy Comprising an Mmp-14 Binding Protein
Application:
61/549,873 →
Rho Kinase Inhibitors
Application:
61/710,373 →
Human Anti-Vegfr-2/Kdr Antibodies
Application:
61/710,420 →
Treatment of Ocular Disease
Application:
61/710,467 →
Immunomodulatory Agents
Application:
61/927,907 →
Treatment of Brain and Central Nervous System Tumors
Application:
61/950,707 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
May 4, 2012
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028156/0742 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0212 →
Security Agreement
Jun 25, 2013
From: KADMON CORPORATION LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030679/0116 →
Assignment of Assignor's Interest
Jun 19, 2014
From: WAKSAL, SAMUEL; CHIANG, LILLIAN
To: KADMON CORPORATION, LLC
Reel/Frame 033142/0681 →
Security Interest
Aug 31, 2015
From: KADMON CORPORATION, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036515/0084 →
Security Interest
Sep 8, 2015
From: KADMON CORPORATION, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036573/0001 →
Nunc Pro Tunc Assignment
Jul 15, 2016
From: CONCORDIA PHARMACEUTICALS, INC.
To: KADMON CORPORATION, LLC
Reel/Frame 039166/0591 →
Assignment of Assignor's Interest
Jul 22, 2016
From: KADMON CORPORATION, LLC
To: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Reel/Frame 039225/0943 →
Corrective Assignment to Correct the Assignor's Name Previously Recorded at Reel: 039166 Frame: 0591. Assignor(S) Hereby Confirms the Assignment.
Aug 16, 2016
From: CONCORDIA PHARMACEUTICALS, LLC
To: KADMON CORPORATION, LLC
Reel/Frame 040314/0329 →
Termination of Patent and Trademark Security Agreement
Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON CORPORATION, LLC
Reel/Frame 051106/0677 →
Assignment of Assignor's Interest
May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
Merger and Change of Name
Sep 10, 2021
From: SURFACE LOGIX, INC.; SURFACE LOGIX, LLC
To: SURFACE LOGIX, LLC
Reel/Frame 057468/0052 →
Release of Security Interest
Oct 21, 2021
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: KADMON CORPORATION, LLC
Reel/Frame 057886/0192 →
Release of Security Interest
Oct 29, 2021
From: MACQUARIE US TRADING LLC
To: KADMON CORPORATION, LLC
Reel/Frame 057973/0751 →
Entity Conversion
Sep 17, 2025
From: SURFACE LOGIX, INC.
To: SURFACE LOGIX LLC
Reel/Frame 072915/0828 →